An ABI ultrasound is a quick, painless test that compares blood pressure in your ankles to blood pressure in your arms, using a handheld Doppler ultrasound probe to detect blood flow. The ratio between those two pressures, called the ankle-brachial index, tells clinicians whether the arteries in your legs have narrowed enough to restrict circulation. A healthy ratio falls between about 1.00 and 1.40, while a number at or below 0.90 suggests peripheral artery disease. The test takes roughly 15 to 20 minutes, requires no needles or contrast dye, and is one of the most commonly used screening tools in vascular medicine.
How the Test Is Performed
The equipment is minimal: a standard blood pressure cuff, a handheld continuous-wave Doppler probe (a small pen-shaped ultrasound device), and ultrasound gel. You lie on your back and rest for several minutes before the measurements begin. That rest period matters because standing or walking beforehand can shift ankle pressures, particularly in people with diabetes, where altered blood pressure regulation in the lower extremities can affect readings.
The technician or clinician measures systolic blood pressure at six sites: both brachial arteries (one in each arm), both dorsalis pedis arteries (on top of each foot), and both posterior tibial arteries (behind each inner ankle bone). At each site, the process follows the same pattern: the cuff is inflated until the Doppler signal disappears, then slowly deflated until the first pulse returns. That return point is the systolic pressure. For each leg, the higher of the two ankle pressures is divided by the higher of the two arm pressures, producing the ABI value for that side.
Continuous-wave Doppler waveform analysis has been a foundation of vascular laboratory testing for decades, and clinicians also pay attention to the shape of the waveforms they hear and see on screen. A normal leg artery produces a sharp, triphasic waveform with a strong forward component, a brief reversal, and a small forward bump. When an artery is significantly narrowed upstream, the waveform flattens out and loses those distinct phases, giving the examiner qualitative information on top of the raw pressure numbers.1Journal for Vascular Ultrasound. Lower-Extremity Arterial Continuous-Wave Doppler Evaluation
What the Numbers Mean
The ABI is a ratio, so interpretation is straightforward. A value between 1.00 and 1.40 is generally considered normal. Values between 0.91 and 0.99 sit in a borderline zone. At 0.90 or below, peripheral artery disease is the likely diagnosis, and the lower the number, the more severe the narrowing. Values above 1.40 point to a different problem: the arteries are so stiffened by calcium deposits that the cuff cannot compress them properly, making the reading unreliable rather than reassuring.
A screening study in a community population found that about 17% of participants had ABI values above 1.3, indicating heavily calcified vessels, while roughly 15% fell in the 0.71 to 0.9 range consistent with mild obstruction.2Warta Pengabdian Andalas. Peripheral Arterial Disease Detection Efforts with Ankle Brachial Index (ABI) Examination Those proportions shift depending on the population being tested. Among people with type 2 diabetes, one study found about a quarter had an ABI below 0.9, and those individuals were far more likely to also have hypertension and a history of smoking.3IAR Journal of Medical Sciences. Screening for Asymptomatic Peripheral Vascular Disease using Ankle Brachial Index among Type 2 Diabetes Mellitus
Even within the range that might seem close to normal, outcomes differ meaningfully. Research comparing survival among ABI categories found that people with values between 0.80 and 0.99 had notably worse cardiovascular and overall survival than those in the 1.00 to 1.29 range. Five-year cardiovascular-death-free survival was about 60% in the lower group versus 87% in the normal group, and five-year overall survival was 42% versus 74%.4PubMed Central. The Cardiovascular-Mortality-Based Estimate for Normal Range of the Ankle-Brachial Index (ABI) Those numbers come from a population that already had reason to be tested, so they reflect a higher-risk group, but the gradient is clear: even mildly depressed ABI carries real prognostic weight.
How Accurate Is the Test
The ABI’s greatest diagnostic strength is specificity. When it says there is a problem, it is almost always right. A structured review of the evidence found specificity ranging from about 83% to 99% for detecting significant arterial narrowing, meaning false positives are uncommon.5PubMed. Sensitivity and specificity of the ankle–brachial index to diagnose peripheral artery disease: a structured review A more recent meta-analysis of diagnostic accuracy in symptomatic patients reported pooled specificity of about 89% and pooled sensitivity of about 65%.6PubMed. Diagnostic Accuracy of Ankle-Brachial Index in Patients With Peripheral Arterial Disease: A Meta-analysis
That sensitivity figure deserves attention. A sensitivity of 65% means roughly a third of people who actually have peripheral artery disease will get a normal ABI result and could be missed. The structured review found sensitivity as low as 15% in certain subgroups, particularly older adults and people with diabetes.5PubMed. Sensitivity and specificity of the ankle–brachial index to diagnose peripheral artery disease: a structured review This is the test’s central limitation: it is much better at confirming disease than at ruling it out. A low ABI is a strong signal. A normal ABI in someone with suggestive symptoms does not necessarily mean the arteries are fine.
Why Diabetes Makes the Test Less Reliable
Diabetes creates a specific and well-documented problem for ABI measurement. The disease accelerates calcification of the arterial walls, particularly in the lower legs. When those walls become rigid, the blood pressure cuff cannot compress them normally, and the recorded ankle pressure ends up artificially high. The result is a falsely normal or even falsely elevated ABI in someone who may actually have significant arterial narrowing underneath the calcified vessel.7PubMed Central. Lower sensitivity of ankle-brachial index measurements among people suffering with diabetes-associated vascular disorders: A systematic review
ABI values above 1.4 are common among people with diabetes precisely because of this calcification effect. That means the test can simultaneously miss disease (by showing a normal-looking number) and signal vessel stiffness (by producing an abnormally high number), and clinicians need to know which pattern they are seeing. A systematic review concluded that diabetes-associated atherosclerosis and vessel wall calcification result in false ABI results, and that patients with significant levels of arterial narrowing may reveal normal or even high ABI values.7PubMed Central. Lower sensitivity of ankle-brachial index measurements among people suffering with diabetes-associated vascular disorders: A systematic review
For this reason, the toe-brachial index is often recommended as a better initial screening tool in people with type 2 diabetes. The small arteries in the toes tend to be spared from the kind of heavy calcification that plagues the tibial arteries at the ankle, so toe pressures give a more trustworthy picture of actual blood flow.8PubMed Central. Toe brachial index and not ankle brachial index is appropriate in initial evaluation of peripheral arterial disease in type 2 diabetes Duplex ultrasound of the distal leg arteries is another alternative. One study found that focused arterial duplex ultrasound at the ankle can be quickly learned even by non-specialists and performed rapidly for early diagnosis in settings like dialysis units, where calcified arteries are especially common.9Progress in Medical Sciences. Ankle Brachial Index (ABI) Versus Point-of-Care Arterial Duplex Ultrasound (DUS) in Early Detection and Diagnosis of Diabetic Foot Ischemia in Hemodialysis Unit
Rest Time and Other Methodological Details That Affect Results
Small procedural details can shift ABI results enough to change a clinical decision. One factor that gets overlooked is how long the patient rests in the supine position before measurement. Transitioning from standing to lying down changes blood distribution, and if ankle pressures are taken too soon, they may not have stabilized. Research has found that this effect is especially pronounced in people with diabetes, where autonomic neuropathy can impair normal blood pressure regulation during positional changes. Reduced sympathetic activity in the feet may cause ankle pressures to behave unpredictably after a person lies down, and the rate of stabilization differs from non-diabetic individuals.10PubMed Central. Effect of Premeasurement Rest Time on Systolic Ankle Pressure
The type of device used also matters. Automated oscillometric machines, which detect arterial pulsation through the cuff rather than using a Doppler probe, have become popular because they are faster and require less training. However, oscillometric errors occur more often in limbs with peripheral artery disease than in healthy limbs. In one study, errors appeared in about 28% of limbs with disease compared to 7% of healthy limbs.11PubMed. Diagnostic accuracy of automated oscillometric determination of the ankle-brachial index in peripheral artery disease The weak, dampened pulses that characterize narrowed arteries are precisely the ones oscillometric sensors have the hardest time reading. This creates a frustrating paradox: the test is least accurate in the patients who need it most.
Exercise ABI Testing
When a person has leg symptoms that sound like peripheral artery disease but a normal resting ABI, the next step is often an exercise test. The principle is simple: walking on a treadmill increases the demand for blood flow in the legs. If an artery is partially narrowed, it may deliver adequate blood at rest but fail to keep up during exertion. Ankle pressures measured immediately after walking will drop in the affected leg, unmasking disease that the resting test missed.
This approach is particularly useful because the resting ABI can look entirely normal in people with moderate blockages that only limit flow under stress. A case report documented a 45-year-old man with bilateral leg claudication whose resting ABI was normal; postexercise testing revealed a significant drop in ankle pressures consistent with moderate atherosclerotic disease.12Journal for Vascular Ultrasound. Exercise Stress Testing Is a Useful Adjunct in the Evaluation of Patients With Claudication and Normal Ankle-Brachial Index
In hemodialysis patients, who have high rates of both arterial disease and vessel calcification, exercise ABI with just one minute of treadmill walking showed substantially better sensitivity than resting ABI alone. The exercise version caught about 86% of cases, compared to roughly 43% with resting ABI. Specificity was somewhat lower with exercise testing, but the overall diagnostic accuracy improved.13PubMed Central. Exercise-ankle brachial pressure index with one-minute treadmill walking in patients on maintenance hemodialysis For clinicians, the takeaway is that a normal resting ABI in a patient who complains of leg pain with walking should not end the workup.
How ABI Compares to Full Duplex Ultrasound
The ABI and full color-duplex ultrasound are often mentioned together, but they answer slightly different questions. The ABI gives a quick pressure-based snapshot of whether flow is restricted somewhere between the heart and the ankle. It does not say where the blockage is or how long it extends. Duplex ultrasound, by contrast, can directly visualize the artery walls, measure the velocity of blood through narrowed segments, and pinpoint the location and severity of individual lesions. Physiologic tests like ABI, toe-brachial index, and pulse volume recordings serve as the gateway evaluation, while duplex ultrasound provides the anatomic detail needed for planning interventions.14PubMed Central. Noninvasive Arterial Testing: What and When to Use
A study comparing the two methods found overall agreement of about 83% between resting ABI and color-duplex findings. Agreement was strongest when disease was severe: a resting ABI below 0.6 matched the duplex result 100% of the time. As the ABI crept closer to normal, agreement declined. At normal ABI levels (0.9 or above), agreement dropped to about 76%, reflecting the ABI’s known tendency to miss milder disease.15PubMed. Comparison of lower limb arterial assessments using color-duplex ultrasound and ankle/brachial pressure index measurements In practice, this means the ABI works well as a screening filter. If it comes back low, the diagnosis is confident. If it comes back normal but symptoms persist, duplex imaging or exercise testing is the reasonable next step.
Predicting Heart Attacks and Strokes
One of the most clinically powerful aspects of the ABI is that it does not just diagnose leg artery disease. A low ABI is a strong independent predictor of heart attack, stroke, and death from cardiovascular causes, because the same atherosclerotic process that narrows leg arteries tends to affect the coronary and carotid arteries too.
A large meta-analysis published in JAMA found that a low ABI (0.90 or below) was associated with roughly twice the ten-year rate of total mortality, cardiovascular mortality, and major coronary events compared to the overall rate within each standard risk category. Ten-year cardiovascular mortality in men with a low ABI was about 19%, versus about 4% in men with a normal index. In women, the corresponding figures were about 13% and 4%. Even after adjusting for traditional risk factors, the hazard remained elevated: about three times the risk for both sexes.16PubMed Central. Ankle Brachial Index Combined with Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis
A separate study tracking patients with suspected peripheral artery disease or elevated cardiovascular risk found that an abnormal ABI roughly doubled the risk of death from all causes and from cardiovascular disease during follow-up. Among those with abnormal ABI who also had a history of prior cardiovascular events, the risks of hospitalization for heart attack and stroke were elevated further, with hazard ratios of about 1.9 and 2.2 respectively.17European Journal of Internal Medicine. Prognostic value of ankle-brachial index in patients with suspected peripheral artery disease or at cardiovascular risk: The Veneto ABI study The ABI, in other words, is not just a leg test. It is a window into systemic vascular health.
Automated Devices and Faster Testing
The traditional Doppler method is accurate but time-consuming and operator-dependent. A trained technician can produce highly reproducible results, but inexperienced operators may struggle to locate signals, especially in patients with weak pulses. Automated oscillometric devices were developed to reduce that skill barrier. Validation studies have shown that automated measurement requires little observer training and significantly increases the reproducibility of ABI estimates compared to the manual approach.18Hypertension Research. Validation of automated oscillometric versus manual measurement of the ankle–brachial index
Speed is another selling point. One comparison found that automated plethysmographic measurements took about 8 minutes on average, while the Doppler method took about 18 minutes per patient.19PubMed. Automated plethysmographic measurement of the ankle-brachial index: a comparison with the doppler ultrasound method Newer oscillometric devices designed specifically for ABI screening have been described as fast enough to use in a general practitioner’s office or even in a nurse-care setting, making screening accessible in places that lack a vascular lab.20Journal of Non Invasive Vascular Investigation. Comparison of Ankle-Brachial Index (ABI) Measurement between a New Oscillometric Device (MESI ABPI Md®) and the Standard Doppler Method in the Diagnosis of Lower Extremity Arterial Disease (LEAD)
The trade-off, as mentioned earlier, is that oscillometric accuracy suffers in the very patients most likely to have disease. For broad screening in a low-risk population, these devices are practical and reasonably accurate. For diagnostic workup in a patient with symptoms or known risk factors like diabetes, the Doppler method remains the standard.
Who Should Get Tested and Whether Screening Pays Off
ABI testing is typically ordered for people with symptoms suggesting poor leg circulation: cramping, pain, or heaviness in the legs during walking that goes away with rest. It is also used as a screening tool in people who have no leg symptoms but carry high cardiovascular risk, such as those with diabetes, a long smoking history, or established coronary artery disease.
Whether routine ABI screening in asymptomatic populations is cost-effective depends heavily on how common the disease is in the group being tested. A cost-effectiveness analysis found that screening high-risk populations like tobacco users, where the expected prevalence of peripheral artery disease is around 23%, brought the cost per quality-adjusted life year down to roughly $24,000, which is generally considered acceptable. That estimate assumed good adherence to the risk-reducing medications that would follow a positive screen.21PubMed Central. Cost Effectiveness Analysis of Asymptomatic Peripheral Arterial Disease Screening with the ABI Test In lower-risk groups, the cost per benefit climbs steeply because most screens will come back normal, and the test’s modest sensitivity means it will still miss some cases.
The economics shift again when the question is not just “does this person have leg artery disease” but “should we add a specific medication based on the result.” An analysis of screening coronary artery disease patients for peripheral artery disease, specifically to guide the addition of low-dose rivaroxaban, concluded that this strategy was not cost-effective at current medication prices because the survival benefit was insufficient to offset the drug cost.22PubMed. Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management Screening decisions, in other words, are not purely about whether the test works. They depend on what you plan to do with the result, how prevalent the disease is in the group you are testing, and whether the downstream interventions actually improve outcomes enough to justify the effort.